James G Davies

DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer

D. McNeel, E. Dunphy, L. Johnson, 2010, Journal of immunotherapy.

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

D. McNeel, G. Wilding, J. Eickhoff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ligand Binding to the Cell‐Surface Receptor for Reovirus Type 3 Alters Schwann Cell Growth and Function

J. Cohen, M. Greene, H. Sehdev, 1990 .